Taiwan Biomaterial Co., Ltd. (6649)

Overview

Taiwan Biomaterial Co., Ltd. is a distinguished entity in the field of medical device development and sales, stationed in Zhubei, Taiwan. Since its establishment in 2010, the company has dedicated itself to advancing medical technologies with a focus on innovative solutions for challenging medical conditions. Their expertise lies in the creation of specialized medical devices aimed at improving patient outcomes in areas such as cerebrovascular surgeries, tissue repair, and osteoarthritis treatment. Through rigorous research and development, Taiwan Biomaterial Co., Ltd. has positioned itself as a key player in Taiwan's medical device industry.

Products and Services

• Foamagen:

A pioneering foamy dura substitute designed by Taiwan Biomaterial Co., Ltd. for neurosurgical procedures. This product aids in replacing or augmenting the dura mater—a thick membrane that surrounds the brain and spinal cord—thereby providing a reliable solution for surgeries requiring dural repair or replacement. Foamagen's innovative design enhances the efficacy and safety of neurosurgical operations.

• Stroke Thrombus Negative Pressure Removal Catheter System:

This comprehensive system addresses the critical need for effective removal of cerebrovascular embolism blood clots. The system includes a specialized pump mechanism for suction and a nickel-titanium guidewire for precise guidance during cerebral vascular surgeries. It represents a significant advancement in the treatment of stroke, offering a minimally invasive option to quickly and safely remove blood clots from the brain's vasculature.

• Tissue Repair and Regeneration Products:

Addressing the growing need for innovative osteoarthritis treatments, Taiwan Biomaterial Co., Ltd. has developed a range of products focused on tissue repair and regeneration. These products are formulated to treat early stages of osteoarthritis by promoting the natural healing and regeneration of tissue. This approach not only alleviates pain and discomfort but also aims to restore the joint's functional integrity, offering a promising solution for millions suffering from this degenerative joint disease.